EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RNA-Based Therapeutic Strategies in Multiple Myeloma: From Molecular Targets to Delivery and Clinical Translation

Maksim V Baranov iD, Igor Shalik, Angela Tsvetkova, Anna Streltsova, Dmitriy Ovcharenko iD, Roman Ivanov iD, Vasiliy Reshetnikov iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27020843 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Maksim V Baranov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia. Hauptthemen laut MEDLINE: Multiple Myeloma, RNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 450 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the grant of the state program of the «Sirius» Federal Territory «Scientific and technological development of the «Sirius» Federal T….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a challenging hematologic malignancy characterized by clonal plasma cell proliferation, often leading to significant morbidity and mortality worldwide. Despite advances in chemotherapy and CAR-T therapies, MM remains incurable due to tumor heterogeneity, immune evasion, and microenvironment remodeling—exacerbated by toxicities like cytokine release syndrome and myelosuppression. This urgent unmet need demands innovative strategies. In this review, we assess cutting-edge RNA-based therapeutics for MM modulation, drawing on preclinical and clinical evidence on modalities including mRNA vaccines, small interfering RNAs (siRNAs), antisense oligonucleotides (ASOs), and microRNA (miRNA) mimics/inhibitors. We further explore RNA-engineered cell therapies, such as transient CAR-T platforms and lipid nanoparticle-delivered systems targeting the bone marrow niche. By integrating these insights, we underscore RNA technologies’ transformative potential to achieve durable remissions, overcome resistance, and reduce costs—paving the way for personalized, safer treatments in refractory MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaRNAHumansAnimalsRNA, Small InterferingMicroRNAsNanoparticlesOligonucleotides, Antisense

Stichwörter der Autor:innen

RNA-therapeuticscell therapieslipid nanoparticlesmultiple myeloma

Substanzen

RNA, Small InterferingMicroRNAsOligonucleotides, AntisenseRNA

Autor:innen und Institutionen

  • Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
  • Independent Researcher, Austin, TX 78748, USA.

ORCID-Profile: Maksim V Baranov, Dmitriy Ovcharenko, Roman Ivanov, Vasiliy Reshetnikov

Förderung

  • This work was supported by the grant of the state program of the «Sirius» Federal Territory «Scientific and technological development of the «Sirius» Federal T…

Zitieren

APA

Baranov, M. V., Shalik, I., Tsvetkova, A., Streltsova, A., Ovcharenko, D., Ivanov, R., & Reshetnikov, V. (2026). RNA-Based Therapeutic Strategies in Multiple Myeloma: From Molecular Targets to Delivery and Clinical Translation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020843

Vancouver

Baranov MV, Shalik I, Tsvetkova A, Streltsova A, Ovcharenko D, Ivanov R, et al. RNA-Based Therapeutic Strategies in Multiple Myeloma: From Molecular Targets to Delivery and Clinical Translation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020843

BibTeX
@article{Baranov2026,
  author = {Baranov, Maksim V and Shalik, Igor and Tsvetkova, Angela and Streltsova, Anna and Ovcharenko, Dmitriy and Ivanov, Roman and Reshetnikov, Vasiliy},
  title = {RNA-Based Therapeutic Strategies in Multiple Myeloma: From Molecular Targets to Delivery and Clinical Translation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27020843}
}
Kostenlos starten →